Reported Jul 18, 2012 · Terminated

Trizivir (abacavir sulfate 300mg, lamivudine 150 mg and zidovudine 300 mg), 60 Tablets, Rx only, Manufactured for: ViiV…

GlaxoSmithKline Inc.

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: GlaxoSmithKline Inc · 1011 North Arendell Ave · Zebulon, NC · 27597-1217

Is this the product you have?

    • Trizivir (abacavir sulfate 300mg
    • lamivudine 150 mg and zidovudine 300 mg)
    • 60 Tablets
    • Rx only
  • Manufactured forViiV Healthcare, Research Triangle Park
  • NC 27709 byGlaxoSmithKline, Research Triangle Park, NC 27709, NDC 49702-217-18
Lot codes and dates
    • Lot #0ZP5128 exp
    • 8/2013
Amount recalled
14,465 bottles

Where it was sold

  • Nationwide

Why it was recalled

Adulterated Presence of Foreign Tablets: Trizivir 300/150/300 mg tables, Lot 0ZP5128 may incorrectly contain Lexiva 700 mg tablets.

This product could cause temporary or reversible health problems — stop using it.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new GlaxoSmithKline Inc. recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (openFDA)

Read the FDA (openFDA drug enforcement) notice

Notice updated Sep 4, 2014 · Data as of Sep 19, 5:50 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.